Helus Pharma Inc. (HELP) vs Zevra Therapeutics, Inc. (ZVRA)
A side-by-side comparison of Helus Pharma Inc. and Zevra Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HELP
Helus Pharma Inc.
$10.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZVRA
Zevra Therapeutics, Inc.
$10.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HELP vs ZVRA
growth of $100 · dividends reinvested · last 1yHELP +93.2% (+93.2%/yr)ZVRA +23.6% (+23.6%/yr)HELP compounded faster over this window
HELP ZVRA
HELP vs ZVRA: by the numbers
- •HELP is the larger company ($667M vs $634M market cap).
- •HELP converts more revenue to profit (329.09% vs 42.82% net margin).
Metrics side by side
Valuation
| Metric | HELP | ZVRA |
|---|---|---|
| P/E ratio | N/A | 11.53 |
| Forward P/E | N/A | 9.68 |
| P/S ratio | N/A | 4.66 |
| P/B ratio | 2.76 | 2.91 |
| EV / EBITDA | N/A | 12.11 |
| FCF yield | N/A | 5.13% |
Profitability
| Metric | HELP | ZVRA |
|---|---|---|
| Gross margin | 100.27% | 84.52% |
| Operating margin | 317.06% | -3.98% |
| Net margin | 329.09% | 42.82% |
| ROE | -75.79% | 26.77% |
| ROIC | -73.27% | 12.93% |
Growth (annualized)
| Metric | HELP | ZVRA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 36.81% |
| Total return CAGR (5Y) | N/A | 3.75% |
Frequently asked
- Is HELP or ZVRA more profitable?
- HELP runs the higher net margin — HELP at 329.09% versus ZVRA at 42.82%.
Go deeper
Dig into the metrics
Zevra Therapeutics P/E ratioHelus Pharma ROEZevra Therapeutics ROEHelus Pharma operating marginZevra Therapeutics operating marginHelus Pharma revenue growthZevra Therapeutics revenue growthHelus Pharma free cash flowZevra Therapeutics free cash flow
Helus Pharma & Zevra Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.